HypertensionResearch article

Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study

HeartPublished

  • INTERASPIRE study
  • standardised interview and examination
  • 14 countries from all six WHO regions

Authors' conclusion

More than one-third of INTERASPIRE patients with CHD presented with BP <120/70 mm Hg, which is below target per current European hypertension guidelines. Further research is needed in this population to resolve discordant guideline recommendations and determine whether de-escalation of BP-lowering therapies is beneficial or even harmful in this setting.

Study context

Population
Adults hospitalised in the previous 6–24 months with incident or recurrent coronary heart disease (CHD), 2020–202321.1% female
Participants
4,548 adults
Comparison
Patients with below-target blood pressure (BP) compared with those at target

Main finding

As reported in the abstract

BP target category · median (IQR) of 1.05 (0.76-1.45) years after index CHD hospitalisation

Further findings

Outcomeabove targetat targetbelow targetP value
Heart failure · more likely with below targetNot reported in the abstract10.0%13.6%P = 0.041
Estimated glomerular filtration rate <60 mL/min/1.73 m² · more likely with below targetNot reported in the abstract10.7%18.9%P < 0.001
Severe frailty · statistically more likely with below targetP = 0.030

Number and cumulative dosing of BP-lowering medications

The median number of BP-lowering medications did not differ significantly between the 3 BP target groups
Cumulative dosing in the below-target group not more intensive than in the at-target group

Age

mean age (±SD)
60.0 (±10.3) years

Original publication

Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study. Heart. Published 26 March 2026. doi:10.1136/heartjnl-2025-327413

Summarised from the published abstract; every number is checked against it